Figure 1

Figure 1: The Hypo intraosseous injection system has a 32-mm 30-gauge needle compatible with standard breech-loading syringes.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 2a

Figure 2a: The Stabident system’s perforator is a 27-gauge 0.43-mm diameter solid core wire imbedded into a plastic sheath designed to engage a standard latch angle.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 2b

Figure 2b: The most apical extent of the attached gingival margins of adjacent teeth is used as a landmark for locating the appropriate perforation point.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 2c

Figure 2c: After application of topical anesthetic and infiltration of local anesthetic into gingival mucosa, perforation is performed mesial or distal to the tooth.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 2d

Figure 2d: After removal of the perforator, the injection needle is introduced to deliver local anesthetic into periradicular medullary bone.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 3a

Figure 3a: The X-Tip system consists of a perforator assembly (solid-core needle with overlying guide sleeve and handle consisting of a stainless steel sheath and plastic hub) and 27-gauge 0.4-mm diameter ultrashort injection needle.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 3b

Figure 3b: Guide sleeve and handle over perforator needle.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 4

Figure 4: The Wand is a computer-controlled system consisting of pump unit, foot pedal, transfuser tubing, handpiece assembly, luer-lock needles and standard anesthetic cartridges.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 5

Figure 5: N-Tralig PDL injection syringe shown with conventional needle and cartridge.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 6a

Figure 6a: Syrijet Mark II jet-injection system: Syrijet syringe, standard dental anesthetic cartridge and plunger rod.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 6b

Figure 6b: Oral tissues are dried and nozzle is rested gently against attached gingiva at right angles. Release of trigger delivers anesthetic.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Figure 6c

Figure 6c: Small residual hematoma and erythema of palatal tissues follows application of jet injection.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table 1            Success rates for conventional inferior alveolar nerve block  

Authors

Drugs used

Total no. of patients

No. of patients with successful anesthesiaa (% success)

Dunbar and others2

2% lidocaine, 1:100,000 epinephrine

40

17 (43)

Clark and others3

2% lidocaine, 1:100,000 epinephrine

30

22 (73)

Reitz and others4

2% lidocaine, 1:100,000 epinephrine

38

27 (71)

Gallatin and others5

3% mepivacaine plain

48

39 (81)

Guglielmo and others6

2% mepivacaine, 1:20,000 levonordefrin

40

32 (80)

Childers and others7

2% lidocaine, 1:100,000 epinephrine

40

25 (63)

Total

 

236

162 (69)

 a    Vital asymptomatic mandibular first molar teeth demonstrating no response to maximum electrical pulp testing output (80 readings) on 2 consecutive tests over 60 minutes in patients who received up to 3.6 mL of local anesthetic to achieve subjective lip numbness at baseline.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table 2               Success rates for conventional inferior alveolar nerve block in patients with irreversible pulpitisa 

Author

Drugs used

Total no. of patients

No. of patients with successful

anesthesiab (% success)

Reisman and others8

3% mepivacaine plain

44

11 (25)

Nusstein and others9

2% lidocaine, 1:100,000 epinephrine

26

10 (38)

Total

 

70

21 (30)

 a    Irreversible pulpitis defined as acute pain, positive response to electrical pulp testing and cold test, sensitivity to percussion and radiographic evidence of a widened periodontal ligament space. 

b                      Success defined as mandibular posterior teeth demonstrating no response to maximum electrical pulp testing output (80 readings) or no response to endodontic access 5 minutes after IANB in patients who received up to 3.6 mL of local anesthetic to achieve subjective lip numbness at baseline.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table 3        

  Reasons for failure of conventional local anesthetic techniques

Armamentarium-related factors

 Deflection of needle tip

                        Inappropriate bevel direction
                        Incorrect needle gauge   

Patient-related factors

 Anatomical

            Accessory innervation (e.g., mylohyoid nerve)
            Barriers to diffusion (e.g., zygomatic buttress)
            Cross-innervation
            Intravascular injection  
            Variation in location of soft- and hard-tissue landmarks relative to mandibular canal
            Unpredictable spread of local anesthetic solution

Pathological

Local infection
Trismus
 Pulpal inflammation  

Psychological 

Operator-related factors  

 Inexperience
            Poor technique 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table 4            Comparison of various systems for adjunctive local anesthesia  

Type of system

System components

Method

Comments

Hypo intraosseous injection system (Fig. 1)

32-mm 30-gauge needle compatible with standard breech-loading syringes; distal 6 mm of needle reinforced with retractable stainless steel sheath (to prevent needle deformation during penetration)

Needle is driven with manual pressure through interproximal interseptal bone or maxillary periapical cortical bone; anesthetic solution is then injected

Obviates need to reintroduce needle after perforation

 

Effectiveness reduced in some situations (e.g., mandibular molar region) because of difficulty in penetrating thicker cortical bone

Stabident intraosseous injection system (Figs. 2a,2b,2c2d)

Single-use perforator (27-gauge, 0.43-mm diameter solid-core wire embedded into plastic sheath designed to engage standard latch angle) and injection needle (0.4-mm diameter hollow-bore bevelled or nonbevelled tipped instrument compatible with standard breech-loading syringes)

Most apical extent of attached gingival margins of adjacent teeth used as landmark for locating appropriate perforation point (cortical bone in mandibular molar region is thinnest within crestal third of alveolar process); after application of topical anesthetic and infiltration of local anesthetic into gingival mucosa, perforation is performed mesial or distal to tooth; after removal of perforator, injection needle is introduced to deliver local anesthetic into periradicular medullary bone

 

X-Tip intraosseous injection system (Figs. 3a and 3b)

Perforator assembly (solid-core needle with overlying guide sleeve and handle consisting of a stainless steel sheath and plastic hub) and 27-gauge 0.4‑mm diameter ultrashort injection needle

Guide sleeve and handle are positioned over perforator needle, which is used to pierce cortical bone, a process that simultaneously introduces the guide sleeve and detachable handle; perforator needle is retracted, and guide sleeve and handle are left in place to facilitate reintroduction of injector needle

Guide sleeve and handle marketed as a means to facilitate reintroduction of injector needle as well as to perform supplemental injections, if required

Wand anesthetic delivery system (Fig. 4)

Computer-controlled system consisting of pump unit, foot pedal, transfuser tubing, handpiece assembly, luer-lock needles and standard anesthetic cartridges

Topical anesthetic is applied, flow is initiated at slow rate, and needle is advanced slowly

Unit may be used for infiltration or nerve block anesthesia

 

May be particularly suited for injection into PDL14

N-Tralig PDL injection system (Fig. 5)

Hand-held injector gun

Needle is inserted at a 30° angle from the long axis of the tooth and directed into proximal gingival sulcus to point of maximum penetration; needle tip is thus wedged between crestal bone and root surface in faciolingual midline15; 0.2 mL of anesthetic is injected under definitive, sustained back pressure; if back pressure is not attained initially, repositioning or insertion at a more apical location is suggested15

Bevel always directed away from root surface

 

Finger or hemostat may be used to stabilize needle on insertion15

 

Injection under marked back pressure is associated with significantly better anesthetic success than injection without such pressure

Siryjet Mark II jet-injection system (Figs. 6a,6b, 6c)

Siryjet syringe, standard dental anesthetic cartridge and plunger rod

Syringe is loaded with anesthetic cartridge, and plunger rod is inserted; rubber nozzle hood is positioned, and syringe is cocked; volume of anesthetic to be dispensed is selected (0.05, 0.10, 0.15, or 0.20 mL); oral tissues are dried, and nozzle is rested gently against attached gingiva (at right angles); release of trigger delivers anesthetic; precise volume can be delivered rapidly under controlled pressure through nozzle penetrating the mucosa or skin (but not hard tissues) to a depth of 1.0-1.5 cm16

To avoid alarming patient, practitioner must discuss procedure with patient in advance, as there is a noticeable popping sound and brief mechanical pressure on activation of the system

 

Small residual hematoma and erythema of palatal tissues follows application of jet injection

 

PDL = periodontal ligament.

 

 

          

 

   

 

 

 

 

 

 

Table 5             Success rates for conventional inferior alveolar nerve block with supplemental intraosseous injection

Author

Drugs used

Total no. of patients

No. of patients with successful anesthesiaa (% success)

Dunbar and others2

2% lidocaine,

1:100,000 epinephrine

40

36 (90)

Reitz and others4

0.9 mL 2% lidocaine,

1:100,000 epinephrine

38

36 (95)

Gallatin and others5

3% mepivacaine plain

48

48 (100)

Reitz and others17

0.9 mL 2% lidocaine, 1:100,000 epinephrine

36

34 (94)

Guglielmo and others6

2% lidocaine,

1:100,000 epinephrine

40

40 (100)

Guglielmo and others6

2% mepivacaine, 1:20,000 levonordefrin

40

40 (100)

Total

 

242

234 (97)

 a        Success defined as mandibular first molars demonstrating no response to maximum electrical pulp testing output (80 readings) on 2 consecutive tests. Patients received up to 3.6 mL of local anesthetic to achieve subjective lip numbness at baseline 2 minutes before the tests.

          

 

 

 

 

 

 

 

 

 

 

 

 

Table 6            Success rates for conventional inferior alveolar nerve block with supplemental intraosseous injection in irreversible pulpitisa 

Author

Drugs used

Total no. of patients

No. of patients with successful anesthesiab(% success)

Reisman and others8

3% mepivacaine plain

44

35 (80)

Nusstein and others9

2% lidocaine,

1:100,00 epinephrine

21

19 (90)

Total

 

65

54 (83)

 a           Irreversible pulpitis defined as acute pain, positive response to electrical pulp testing and cold test, sensitivity to percussion and radiographic evidence of a widened periodontal ligament space. 

b          Success defined as mandibular posterior teeth demonstrating no response to maximum electrical pulp testing output (80 readings) or no response to endodontic access 5 minutes after IANB and intraosseous injection. All patients received up to 3.6 mL of local anesthetic to achieve subjective lip numbness at baseline.